These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 35775883

  • 1. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
    Christopher H, Josephat E, Kaywanga F, Saul S, Mshana I, Kunambi P, Nasser A, Chamba C, Makani J, Nkya S.
    Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883
    [Abstract] [Full Text] [Related]

  • 2. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.
    Mano RM, Kuona P, Misihairabgwi JM.
    BMC Pediatr; 2024 May 10; 24(1):323. PubMed ID: 38730340
    [Abstract] [Full Text] [Related]

  • 3. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA, Hustace T, Voltaire M, Mantero A, Liberus U, Saint Fleur R.
    Pediatrics; 2019 Oct 10; 144(4):. PubMed ID: 31530717
    [Abstract] [Full Text] [Related]

  • 4. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
    Eastburg L, Peckham A, Kawira E, Chirangi B, Adler D, Akungo BD, Smart LR, Ambrose EE.
    Pediatr Blood Cancer; 2020 Nov 10; 67(11):e28620. PubMed ID: 32803850
    [Abstract] [Full Text] [Related]

  • 5. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
    Nkya S, Mtei L, Soka D, Mdai V, Mwakale PB, Mrosso P, Mchoropa I, Rwezaula S, Azayo M, Ulenga N, Ngido M, Cox SE, D'Mello BS, Masanja H, Kabadi GS, Mbuya F, Mmbando B, Daniel Y, Streetly A, Killewo J, Tluway F, Lyimo M, Makani J.
    Int Health; 2019 Nov 13; 11(6):589-595. PubMed ID: 31145786
    [Abstract] [Full Text] [Related]

  • 6. Using dried blood spot on HemoTypeSC™, a new frontier for newborn screening for sickle cell disease in Nigeria.
    Okeke CO, Chianumba RI, Isa H, Asala S, Nnodu OE.
    Front Genet; 2022 Nov 13; 13():1013858. PubMed ID: 36386848
    [Abstract] [Full Text] [Related]

  • 7. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Steele C, Sinski A, Asibey J, Hardy-Dessources MD, Elana G, Brennan C, Odame I, Hoppe C, Geisberg M, Serrao E, Quinn CT.
    Am J Hematol; 2019 Jan 13; 94(1):39-45. PubMed ID: 30290004
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.
    Smart LR, Ambrose EE, Raphael KC, Hokororo A, Kamugisha E, Tyburski EA, Lam WA, Ware RE, McGann PT.
    Ann Hematol; 2018 Feb 13; 97(2):239-246. PubMed ID: 29147848
    [Abstract] [Full Text] [Related]

  • 9. Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests.
    Olaniyan HS, Briscoe C, Muhongo M, Pascoal R, Armando A, Santos B, McGann PT.
    Blood Adv; 2023 Oct 10; 7(19):5860-5867. PubMed ID: 37399450
    [Abstract] [Full Text] [Related]

  • 10. A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies.
    Quinn CT, Paniagua MC, DiNello RK, Panchal A, Geisberg M.
    Br J Haematol; 2016 Nov 10; 175(4):724-732. PubMed ID: 27605462
    [Abstract] [Full Text] [Related]

  • 11. Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia.
    Adegoke SA, Makalo L, Sallah A, Saine H, Joof S, Conteh A, Bah R, Camara Jammeh AF, Bass M, Jallow M, Nnodu OE.
    Hemoglobin; 2024 May 10; 48(3):169-174. PubMed ID: 38980121
    [Abstract] [Full Text] [Related]

  • 12. Using DNA testing for the precise, definite, and low-cost diagnosis of sickle cell disease and other Haemoglobinopathies: findings from Tanzania.
    Christopher H, Burns A, Josephat E, Makani J, Schuh A, Nkya S.
    BMC Genomics; 2021 Dec 16; 22(1):902. PubMed ID: 34915846
    [Abstract] [Full Text] [Related]

  • 13. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood.
    Guindo A, Cisse Z, Keita I, Desmonde S, Sarro YDS, Touré BA, Baraika MA, Tessougué O, Guindo P, Coulibaly M, Traore O, Sylla N, Diassana M, Saye A, Picot V, Lauressergues E, Leroy V.
    Br J Haematol; 2024 Jan 16; 204(1):337-345. PubMed ID: 37728227
    [Abstract] [Full Text] [Related]

  • 14. Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.
    Oluwole EO, Adeyemo TA, Osanyin GE, Odukoya OO, Kanki PJ, Afolabi BB.
    PLoS One; 2020 Jan 16; 15(12):e0242861. PubMed ID: 33270733
    [Abstract] [Full Text] [Related]

  • 15. HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.
    Nnodu O, Isa H, Nwegbu M, Ohiaeri C, Adegoke S, Chianumba R, Ugwu N, Brown B, Olaniyi J, Okocha E, Lawson J, Hassan AA, Diaku-Akinwumi I, Madu A, Ezenwosu O, Tanko Y, Kangiwa U, Girei A, Israel-Aina Y, Ladu A, Egbuzu P, Abjah U, Okolo A, Akbulut-Jeradi N, Fernandez M, Piel FB, Adekile A.
    Blood Cells Mol Dis; 2019 Sep 16; 78():22-28. PubMed ID: 30773433
    [Abstract] [Full Text] [Related]

  • 16. Multicenter Evaluation of HemoTypeSC as a Point-of-Care Sickle Cell Disease Rapid Diagnostic Test for Newborns and Adults Across India.
    Mukherjee MB, Colah RB, Mehta PR, Shinde N, Jain D, Desai S, Dave K, Italia Y, Raicha B, Serrao E.
    Am J Clin Pathol; 2020 Jan 01; 153(1):82-87. PubMed ID: 31433854
    [Abstract] [Full Text] [Related]

  • 17. A Paper-Based Test for Screening Newborns for Sickle Cell Disease.
    Piety NZ, George A, Serrano S, Lanzi MR, Patel PR, Noli MP, Kahan S, Nirenberg D, Camanda JF, Airewele G, Shevkoplyas SS.
    Sci Rep; 2017 Apr 03; 7():45488. PubMed ID: 28367971
    [Abstract] [Full Text] [Related]

  • 18. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
    Nnodu OE, Sopekan A, Nnebe-Agumadu U, Ohiaeri C, Adeniran A, Shedul G, Isa HA, Owolabi O, Chianumba RI, Tanko Y, Iyobosa JH, Adekile AD, Olopade OI, Piel FB.
    Lancet Haematol; 2020 Jul 03; 7(7):e534-e540. PubMed ID: 32589979
    [Abstract] [Full Text] [Related]

  • 19. Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
    Dexter D, McGann PT.
    Br J Haematol; 2022 Jan 03; 196(1):63-69. PubMed ID: 34340260
    [Abstract] [Full Text] [Related]

  • 20. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB, Awad S, Happich M, Muckenthaler L, Lindner M, Gramer G, Okun JG, Hoffmann GF, Bruckner T, Muckenthaler MU, Kulozik AE.
    Ann Hematol; 2016 Feb 03; 95(3):397-402. PubMed ID: 26658910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.